Private Equity

The strategic acquisition of 70-year-old Stamford Tent by New York Tent's parent company signals a major consolidation in the booming Northeast event market.

A wellness company is calling out the supplement industry, claiming many popular shilajit gummies are ineffective, candy-like products. Here's what's real.

The Brazilian churrasco giant reveals plans for 14-16 new restaurants, pushing into new international markets and innovating beyond the grill.

Private equity firm Five Arrows makes a majority investment in Blue Mountain to fuel AI innovation, product growth, and European expansion for its compliance software.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

Following a $25M fundraise, former WA Health Secretary Dr. Shah joins Jaan Health, signaling a new era for AI-driven chronic disease management.

Under new ownership, the iconic food brand is sponsoring Ricky Stenhouse Jr. at Daytona and launching a record fan giveaway in a bold comeback play.

As the SF Zoo faces a financial crisis, a poll reveals overwhelming public support for a bold plan to replace it with a $350M conservation-focused EcoPark.

Avalon GloboCare regains Nasdaq compliance, but its future is being reshaped by a bold AI launch and a transformative merger that questions its identity.

Organ transplant innovator TransMedics is leasing a 498,000 sq ft facility in Somerville, a move set to scale its life-saving tech and boost Boston's biotech scene.

A partnership between Pacific General and S Food will inject global innovation and Korean-inspired products into an 84-year-old American deli brand.

The Nashville hot chicken giant appoints a new franchise VP to manage its explosive growth, targeting Europe, Asia, and non-traditional US locations.

Tech consultancy Hylaine hires veteran exec Doug Hautop as President to lead an aggressive plan to scale, targeting Fortune 1000 enterprise clients.

Following a successful three-year transformation, B-FLEXION acquires full ownership of Radius Health, betting big on its blockbuster osteoporosis drug TYMLOS®.

Private equity firm Sole Source Capital acquires cybersecurity provider Brite, signaling a major 'buy-and-build' play in a booming, fragmented market.

FDA clears a novel two-part immunotherapy that paints solid tumors with a synthetic target, unleashing a powerful CAR T-cell attack in a new clinical trial.

The insurance giant landed a major credit facility, calming investor nerves and doubling down on its fast-growing pharmacy and healthcare services arm.

Leasing begins at The Orchard, a new luxury giant in Long Island City. But as it sets records, it also raises questions about the neighborhood's future.

AbbVie inks a massive deal for a novel bispecific antibody, aiming to combine it with ADCs and enter the high-stakes race for solid tumor therapies.

The genomics leader posted a 41% revenue surge in 2025 and projects profitability, yet its stock tumbled on what some see as conservative 2026 guidance.